The role of antitumor drugs in treating stomach cancer patients

Garin, A.M.; Bazin, I.S.

Terapevticheskii Arkhiv 69(2): 16-18

1997


ISSN/ISBN: 0040-3660
PMID: 9173567
Document Number: 471553
The treatment of advanced gastric carcinoma is a challenge to oncologists. Within the last 6-7 years several new regimens have been introduced: EAP, FAMTX, MEP, MVP, ELF. Overall response rate of these schemes is 30-40%, a complete response seldom reaching 10%. Anticancer drugs significantly improve quality of life. Chemotherapy of advanced cancer is the method of choice. New combinations and regimens may appear promising.

Document emailed within 1 workday
Secure & encrypted payments